- Comirnaty, Pfizer’s COVID-19 vaccine: The name represents a combination of the terms COVID-19, mRNA, community and immunity.
- Spikevax, Moderna’s COVID-19 vaccine: The first part of the name refers to the “spike” glycoprotein on the coronavirus.
- Vaxzevria, AstraZeneca’s COVID-19 vaccine: Including the “evri” sound in the name is intended to communicate that the vaccine is for everyone.
- Nuvaxovid, Novavax’s COVID-19 vaccine: The vaccine’s name was designed to share a similar cadence to the drugmaker’s name without an explicit association.
- Vidprevtyn, Sanofi and GlaxoSmithKline’s COVID-19 vaccine: The first syllable of the name likely refers to COVID-19, and the second syllable is likely meant to represent disease prevention, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
